Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NAPB | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | UBE3A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SLF2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP11-458D21.5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | ZBTB37 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CERCAM | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CORO1A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | PRY | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | P2RY1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | KDSR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |